Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A double-blind trial of the effect of transfer factor on multiple sclerosis patients was carried out. In a series of fifty-six multiple sclerosis patients treated with monthly injections of either transfer factor or placebo for 1 year, no beneficial effect of transfer factor was noted. In addition, none of the immunological and serological parameters studied (measles migration inhibition, measles HI titre or CSF immunoglobulin) changed as a result of transfer factor therapy. Histocompatibility typing and CSF IgG/TP ratios were correlated with the disease activity. Of interest was the finding that the presence of the DW2 antigen, when unassociated with HLA-B7 antigen, appeared to correlate with the mildest form of disease activity.

Type

Journal article

Journal

Clin Exp Immunol

Publication Date

07/1978

Volume

33

Pages

1 - 11

Keywords

Adult, Cell Migration Inhibition, Clinical Trials as Topic, Double-Blind Method, Female, Histocompatibility Antigens, Histocompatibility Testing, Humans, Immunoglobulin G, Male, Multiple Sclerosis, Transfer Factor